Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: May 21, 2010

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Tom Joyce assumed the role of President of AB Sciex in mid April and is now responsible for the day-to-day operations of the company, in addition to continuing in his role as executive vice president for Danaher Corporation. Also in mid-April, Andy Boorn assumed the role of Chief Operating Officer for AB SCIEX. Laura Lauman, who joined AB Sciex from Life Technologies and served as president along with Boorn, has left the firm to "pursue other career opportunities," an AB Sciex spokesperson told GenomeWeb Daily News.

Jack Zakowski has been elected to the board of directors of the Clinical and Laboratory Standards Institute (CLSI), and will serve a three-year term as CLSI's secretary. He currently is director of scientific affairs and professional relations at Beckman Coulter.

As part of a restructuring at Helicos BioSciences, Bill Efcavitch has stepped down as senior vice president and chief technology officer and has become a senior advisor to the company's CEO. He is expected to remain a full-time employee until June 30 but will no longer serve as an executive officer of the company.

Caris Life Sciences has tapped Jonathan Knowles to serve as chief scientific officer, a new position at the company. In the role, Knowles will be responsible for expanding the company's overall scientific research capabilities and overseeing the development of novel and proprietary assays that use the Carisome platform. Knowles has been a professor of translational medicine at EPFL in Switzerland, and he has been a professor at the Institute for Molecular Medicine at the University of Helsinki.

Prior to joining Caris, Knowles was president of Group Research at Roche and was a member of Roche's corporate executive committee. He also served as a member of the Genentech board of directors for 12 years and chairman of the corporate governance committee for Genentech, and was a member of the Chugai Pharmaceutical board.

WIL Research Company has named David Spaight to be CEO, and he has been appointed to a seat on the board of directors. Spaight formerly was president of MDS Pharma Services, he was senior VP at Fisher Scientific Products, and he spent 20 years with PerkinElmer Life and Analytical Sciences.

IncellDx has appointed Brandon Steele to be VP of commercial operations. He will be responsible for the commercialization of the HPV OncoTect test and other products. Steele formerly was VP of commercial operations at Applied Imaging, and he has held various positions at Nanogen, Gen-Probe, and Bayer Diagnostics.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.